生命科学资讯

Roche returns to MediLink with promise of $570M near-term payments for another ADC

Medipost gets $140M to take Korean stem cell therapy into US

Gene editing pioneers launch first startup focused on custom CRISPR therapies

Aurora sets out to capitalize on FDA’s new framework for bespoke drug therapies

Roche returns to MediLink with $570M near-term payments for ADC - Fierce Biotech

Robeco Institutional Asset Management B.V. Acquires 26,573 Shares of Agilent Technologies, Inc. $A - MarketBeat

Stifel raises Thermo Fisher Scientific stock price target to $700 on biopharma growth outlook - Investing.com

Stifel raises Thermo Fisher Scientific stock price target to $700 on biopharma growth outlook - Investing.com India

Illumina hires former NHGRI director Eric Green as new chief medical officer - Fierce Biotech

Agilent Technologies: Why Execution Matters Most When the Cycle Turns - Investing.com

Agilent Technologies: Why Execution Matters Most When the Cycle Turns - Investing.com

Illumina and PREMIA partner to expand clinical access to CGP in Asia - TheWire.in

Why Waters Corporation stock remains on buy lists - Chart Signals & Low Risk Entry Point Tips - ulpravda.ru

Aktis lands biotech's first IPO of 2026, raising $318M for radiopharmaceuticals

Aktis raises $318M in 2026’s first biotech IPO

OpenAI brings ChatGPT to hospitals on the heels of launching consumer health tool

Why Waters Corporation stock remains on buy lists - Global Markets & Precise Buy Zone Identification - ulpravda.ru

Assessing 10x Genomics (TXG) Valuation After Recent Share Price Momentum Shift - Yahoo Finance

Ollin eyes phase 3 after bispecific tops Vabysmo in early-stage trial, clearing more retinal disease faster

The interplay between biomolecular assembly and phase separation